Hyperhomocysteinemia and Occlusive Vascular Disease

Mild hyperhomocysteinemia and arterial occlusive disease.

Hyperhomocysteinemia and occlusive vascular disease: an emergent role for fibroblast growth factor 2.

Occlusive vascular disease is the leading cause of mortality and disability in the Western world. Based in accumulated previous evidence, in 1991 Clarke et al identified hyperhomocysteinemia as a new independent risk factor for vascular disease.1 Since then, hyperhomocysteinemia has been associated with an increased risk of cardiovascular disease, including atherosclerosis, thrombosis, stroke, ...

HIV-occlusive vascular disease.

OBJECTIVES To evaluate peripheral arterial occlusive disease in HIV-infected patients regarding clinical presentation and outcome of surgical intervention. DESIGN Prospective clinical survey. PATIENTS AND METHODS Routine voluntary testing for HIV/AIDS was performed in all patients presenting to our vascular unit. HIV+ patients were enrolled in a registry and followed up prospectively. RES...

Fibrinolysis and Occlusive Vascular Disease

Based on a Dissertation read before the Royal Medical Society on Friday. 20th January, 1961. The magnitude of the problem of occlusive vascular disease needs no introduction ; we should therefore be acquaint with any new therapeutic developments, particularly if these h a v e reached the stage of clinical trials. I apologise for any bias and simplification in this article. The purpose of the or...

Hyperhomocysteinemia, MTHFR, and risk of vascular disease.

tables or figures and should relate solely to an article published in Circulation within the preceding 12 weeks. Authors of letters selected for publication will receive prepublication proofs, and authors of the article cited in the letter will be invited to reply. Replies must be signed by all authors listed in the original publication. Please submit three typewritten, double-spaced copies of ...